{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T06:55:13Z","timestamp":1764053713878,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Startup Fund for scientific research of Fujian Medical University","award":["2019QH1270"],"award-info":[{"award-number":["2019QH1270"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Bronchopulmonary dysplasia (BPD) infants present an increased incidence of metabolic bone disease (MBD), but it is unknown which factors contribute to this. The aim of this study was to determine the risk factors for developing MBD in BPD infants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective review of the medical records of BPD infants admitted to the Neonatal intensive care unit at Zhangzhou Hospital between Jun 2016 and May 2020 was performed. BPD infants with MBD were identified, two contemporaneous without MBD matched by gestational age and gender were randomly selected as controls for each case of MBD. The association between putative risk factors and MBD was estimated with ORs and 95% CIs. A <jats:italic>P<\/jats:italic>-value threshold \u22640.2 was used in univariate analysis for inclusion into a multivariate (adjusted) model with a <jats:italic>P<\/jats:italic>-value of &lt;\u20090.05 as statistically significant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 156 BPD infants were enrolled with 52 cases of MBD and 104 controls. Fetal growth restriction (OR 6.00, 95% CI, 1.81\u201319.84), extremely low birth weight (OR 3.10, 95% CI, 1.07\u20138.94), feeding volume\u2009&lt;\u200980\u2009mL\/kg\/d at the end of the 4<jats:bold>th<\/jats:bold> week after birth (OR 14.98, 95% CI, 4.04\u201355.58), cholestasis (OR 4.44, 95% CI, 1.59\u201312.40), late onset sepsis (OR 3.95, 95% CI, 1.12\u201313.98) and prolonged (&gt;\u20092\u2009weeks) diuretics application (OR 5.45, 95% CI, 1.25\u201323.84) were found to be statistically significant risk factors for MBD in BPD infants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In BPD infants of homogeneous gestational age, fetal growth restriction, extremely low birth weight, feeding volume\u2009&lt;\u200980\u2009mL\/kg\/d at the end of the 4th week after birth, cholestasis and late onset sepsis are significant risk factors for MBD. These findings provide potential predictive factors for MBD in BPD infants and warrant prospective validation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-021-02705-0","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T06:02:47Z","timestamp":1621231367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Risk factors for metabolic bone disease among preterm infants less than 32\u2009weeks gestation with Bronchopulmonary dysplasia"],"prefix":"10.1186","volume":"21","author":[{"given":"Wenwen","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzhen","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0296-0019","authenticated-orcid":false,"given":"Liping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,17]]},"reference":[{"key":"2705_CR1","doi-asserted-by":"publisher","unstructured":"Faienza MF, D'Amato E, Natale MP, Grano M, Chiarito M, Brunetti G, et al. Metabolic bone disease of prematurity: diagnosis and management. Front Pediatr. 2019; 7: 143. doi: https:\/\/doi.org\/10.3389\/fped.2019.00143. PMID: 31032241; PMCID: PMC6474071.","DOI":"10.3389\/fped.2019.00143"},{"key":"2705_CR2","doi-asserted-by":"publisher","unstructured":"Gaio P, Verlato G, Daverio M, Cavicchiolo ME, Nardo D, Pasinato A, de Terlizzi F, Baraldi E Incidence of metabolic bone disease in preterm infants of birth weight <1250 g and in those suffering from bronchopulmonary dysplasia. Clin Nutr ESPEN 2018; 23: 234\u2013239. doi: https:\/\/doi.org\/10.1016\/j.clnesp.2017.09.008. PMID: 29460805.","DOI":"10.1016\/j.clnesp.2017.09.008"},{"key":"2705_CR3","doi-asserted-by":"publisher","unstructured":"Jensen EA, White AM, Liu P, Yee K, Waber B, Monk HM, Zhang H Determinants of severe metabolic bone disease in very low-birth-weight infants with severe Bronchopulmonary dysplasia admitted to a tertiary referral center. Am J Perinatol 2016; 33(1): 107\u2013113. doi: https:\/\/doi.org\/10.1055\/s-0035-1560043. PMID: 26295968.","DOI":"10.1055\/s-0035-1560043"},{"key":"2705_CR4","doi-asserted-by":"publisher","unstructured":"Costa R, Franco C, Santos N, Maio P, Vieira F, Antunes S, et al. Metabolic bone disease of prematurity in very low birthweight infants: retrospective observational study. Acta Med Port. 2019; 32(7\u20138): 536\u2013541. doi: https:\/\/doi.org\/10.20344\/amp.10994. PMID: 31445534.","DOI":"10.20344\/amp.10994"},{"key":"2705_CR5","doi-asserted-by":"publisher","unstructured":"Chen W, Yang C, Chen H, Zhang B. Risk factors analysis and prevention of metabolic bone disease of prematurity. Medicine (Baltimore). 2018; 97(42): e12861. doi: https:\/\/doi.org\/10.1097\/MD.0000000000012861. PMID: 30334994; PMCID: PMC6211899.","DOI":"10.1097\/MD.0000000000012861"},{"key":"2705_CR6","doi-asserted-by":"publisher","unstructured":"Montaner Ram\u00f3n A, Fern\u00e1ndez Espuelas C, Calmarza Calmarza P, Rite Gracia S, Oliv\u00e1n Del Cacho MJ. Risk factors and biochemical markers in metabolic bone disease of premature newborns. Rev Chil Pediatr 2017; 88(4): 487\u2013494. doi: https:\/\/doi.org\/10.4067\/S0370-41062017000400007. PMID: 28898316.","DOI":"10.4067\/S0370-41062017000400007"},{"key":"2705_CR7","doi-asserted-by":"publisher","unstructured":"Ukarapong S, Venkatarayappa SKB, Navarrete C, Berkovitz G. Risk factors of metabolic bone disease of prematurity. Early Hum Dev 2017; 112:29\u201334. doi: https:\/\/doi.org\/10.1016\/j.earlhumdev.2017.06.010. PMID: 28683339.","DOI":"10.1016\/j.earlhumdev.2017.06.010"},{"key":"2705_CR8","doi-asserted-by":"publisher","unstructured":"Higgins RD, Jobe AH, Koso-Thomas M, Bancalari E, Viscardi RM, Hartert TV, et al. Bronchopulmonary dysplasia: executive summary of a workshop. J Pediatr. 2018; 197:300\u2013308. doi: https:\/\/doi.org\/10.1016\/j.jpeds.2018.01.043. PMID: 29551318; PMCID: PMC5970962.","DOI":"10.1016\/j.jpeds.2018.01.043"},{"key":"2705_CR9","doi-asserted-by":"publisher","unstructured":"Backstr\u00f6m MC, Kouri T, Kuusela AL, Siev\u00e4nen H, Koivisto AM, Ikonen RS, M\u00e4ki M Bone isoenzyme of serum alkaline phosphatase and serum inorganic phosphate in metabolic bone disease of prematurity. Acta Paediatr 2000; 89(7): 867\u2013873. PMID: 10943972, DOI: https:\/\/doi.org\/10.1111\/j.1651-2227.2000.tb00395.x.","DOI":"10.1111\/j.1651-2227.2000.tb00395.x"},{"key":"2705_CR10","doi-asserted-by":"publisher","unstructured":"Torchin H, Lorthe E, Goffinet F, Kayem G, Subtil D, Truffert P, et al. Histologic chorioamnionitis and bronchopulmonary dysplasia in preterm infants: the epidemiologic study on low gestational ages 2 cohort. J Pediatr. 2017; 187:98\u2013104.e3. doi: https:\/\/doi.org\/10.1016\/j.jpeds.2017.05.019. PMID: 28583707","DOI":"10.1016\/j.jpeds.2017.05.019"},{"key":"2705_CR11","doi-asserted-by":"publisher","unstructured":"Salvador A, Janeczko M, Porat R, Sekhon R, Moewes A, Schutzman D. Randomized controlled trial of early parenteral nutrition cycling to prevent cholestasis in very low birth weight infants. J Pediatr. 2012; 161(2): 229\u2013233.e1. doi: https:\/\/doi.org\/10.1016\/j.jpeds.2012.02.003. PMID: 22424948.","DOI":"10.1016\/j.jpeds.2012.02.003"},{"key":"2705_CR12","unstructured":"Leeman L, Dresang LT, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician 2016; 93(2): 121\u2013127. PMID: 26926408."},{"key":"2705_CR13","doi-asserted-by":"publisher","unstructured":"Kahveci H, Tayman C, Lalo\u011flu F, Kavas N, Ciftel M, Y\u0131lmaz O, et al. Relationship between hemodynamically significant ductus arteriosus and ischemia-modified albumin in premature infants. Indian J Clin Biochem. 2016; 31(2): 231\u2013236. doi: https:\/\/doi.org\/10.1007\/s12291-015-0523-z. PMCID: PMC4820428.","DOI":"10.1007\/s12291-015-0523-z"},{"key":"2705_CR14","doi-asserted-by":"publisher","unstructured":"Hashemipour M, Hovsepian S, Ansari A, Keikha M, Khalighinejad P, Niknam N. Screening of congenital hypothyroidism in preterm, low birth weight and very low birth weight neonates: a systematic review. Pediatr Neonatol 2018; 59(1): 3\u201314. doi: https:\/\/doi.org\/10.1016\/j.pedneo.2017.04.006. PMID: 28811e156","DOI":"10.1016\/j.pedneo.2017.04.006"},{"key":"2705_CR15","doi-asserted-by":"publisher","unstructured":"Kulkarni VV, Dutta S, Sundaram V, Saini SS. Preterm thrombocytopenia and delay of Ductus Arteriosus closure. Pediatrics. 2016; 138(4): e20161627. doi: https:\/\/doi.org\/10.1542\/peds.2016-1627. PMID: 27681010.","DOI":"10.1542\/peds.2016-1627"},{"key":"2705_CR16","doi-asserted-by":"publisher","unstructured":"Alcock G, Liley HG, Cooke L, Gray PH. Prevention of neonatal late-onset sepsis: a randomised controlled trial. BMC Pediatr. 2017; 17(1): 98. doi: https:\/\/doi.org\/10.1186\/s12887-017-0855-3. PMID: 28376891; PMCID: PMC5381090.","DOI":"10.1186\/s12887-017-0855-3"},{"key":"2705_CR17","doi-asserted-by":"publisher","unstructured":"Wood CL, Wood AM, Harker C, Embleton ND. Bone mineral density and osteoporosis after preterm birth: the role of early life factors and nutrition. Int J Endocrinol. 2013; 2013: 902513. doi: https:\/\/doi.org\/10.1155\/2013\/902513. PMID: 23662104; PMCID: PMC3639624.","DOI":"10.1155\/2013\/902513"},{"issue":"23","key":"2705_CR18","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1113\/JP279532","volume":"598","author":"S Lager","year":"2020","unstructured":"Lager S, Sovio U, Eddershaw E, van der Linden MW, Yazar C, Cook E, et al. Abnormal placental CD8+ T-cell infiltration is a feature of fetal growth restriction and pre-eclampsia. J Physiol. 2020;598(23):5555\u201371. 32886802. https:\/\/doi.org\/10.1113\/JP279532.","journal-title":"J Physiol"},{"key":"2705_CR19","doi-asserted-by":"publisher","unstructured":"Viswanathan S, Khasawneh W, McNelis K, Dykstra C, Amstadt R, Super DM, Groh-Wargo S, Kumar D Metabolic bone disease: a continued challenge in extremely low birth weight infants. JPEN J Parenter Enteral Nutr 2014; 38(8): 982\u2013990. doi: https:\/\/doi.org\/10.1177\/0148607113499590. PMID: 23963689.","DOI":"10.1177\/0148607113499590"},{"key":"2705_CR20","doi-asserted-by":"publisher","unstructured":"Lee SM, Namgung R, Park MS, Eun HS, Park KI, Lee C. High incidence of rickets in extremely low birth weight infants with severe parenteral nutrition-associated cholestasis and bronchopulmonary dysplasia. J Korean Med Sci. 2012; 27(12): 1552\u20131555. doi: https:\/\/doi.org\/10.3346\/jkms.2012.27.12.1552. PMID: 23255857; PMCID: PMC3524437.","DOI":"10.3346\/jkms.2012.27.12.1552"},{"key":"2705_CR21","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.earlhumdev.2010.09.053","volume":"86","author":"S Bandara","year":"2010","unstructured":"Bandara S, Kariyawasam A. Incidence of osteopenia of prematurity in preterm infants who were exclusively fed breast milk. Early Hum Dev. 2010;86:S18. https:\/\/doi.org\/10.1016\/j.earlhumdev.2010.09.053.","journal-title":"Early Hum Dev"},{"key":"2705_CR22","doi-asserted-by":"publisher","unstructured":"Figueras-Aloy J, \u00c1lvarez-Dom\u00ednguez E, P\u00e9rez-Fern\u00e1ndez JM, Moretones-Su\u00f1ol G, Vidal-Sicart S, Botet-Mussons F. Metabolic bone disease and bone mineral density in very preterm infants. J Pediatr 2014; 164(3): 499\u2013504. doi: https:\/\/doi.org\/10.1016\/j.jpeds.2013.10.089. PMID: 24331689.","DOI":"10.1016\/j.jpeds.2013.10.089"},{"key":"2705_CR23","doi-asserted-by":"publisher","unstructured":"Samra NM, Emad El Abrak S, El Dash HH, El Said El Raziky M, El Sheikh MA. Evaluation of vitamin D status bone mineral density and dental health in children with cholestasis. Clin Res Hepatol Gastroenterol 2018; 42(4): 368\u2013377. doi: https:\/\/doi.org\/10.1016\/j.clinre.2017.11.010. PMID: 29551613.","DOI":"10.1016\/j.clinre.2017.11.010"},{"key":"2705_CR24","doi-asserted-by":"publisher","unstructured":"Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh. W, Bauer CR, Korones SB, Shankaran S, Laptook AR, Stevenson DK, Papile LA, Poole WK Late-onset sepsis in very low birth weight neonates: the experience of the NICHD neonatal research network. Pediatrics. 2002; 110(2 Pt 1): 285\u2013291. doi: https:\/\/doi.org\/10.1542\/peds.110.2.285. PMID: 12165580.","DOI":"10.1542\/peds.110.2.285"},{"key":"2705_CR25","doi-asserted-by":"publisher","unstructured":"Horowitz MC, Fretz JA, Lorenzo JA. How B cells influence bone biology in health and disease. Bone. 2010; 47(3): 472\u2013479. doi: https:\/\/doi.org\/10.1016\/j.bone.2010.06.011. PMID: 20601290; PMCID: PMC2941392.","DOI":"10.1016\/j.bone.2010.06.011"},{"key":"2705_CR26","doi-asserted-by":"publisher","unstructured":"Dusad A, Thiele GM, Klassen LW, Gleason AM, Bauer C, Mikuls TR, et al. Organic dust, lipopolysaccharide, and peptidoglycan inhalant exposures result in bone loss\/disease. Am J Respir Cell Mol Biol. 2013; 49(5): 829\u2013836. doi: https:\/\/doi.org\/10.1165\/rcmb.2013-0178OC. PMID: 23782057; PMCID: PMC3931104.","DOI":"10.1165\/rcmb.2013-0178OC"},{"key":"2705_CR27","doi-asserted-by":"publisher","unstructured":"Aceti A, Maggio L, Beghetti I, Gori D, Barone G, Callegari ML, et al. Probiotics prevent late-onset sepsis in human milk-fed, very low birth weight preterm infants: systematic review and meta-analysis. Nutrients. 2017; 9(8): 904. doi: https:\/\/doi.org\/10.3390\/nu9080904. PMID: 28829405; PMCID: PMC5579697.","DOI":"10.3390\/nu9080904"},{"key":"2705_CR28","doi-asserted-by":"publisher","unstructured":"Hagadorn JI, Sanders MR, Staves C, Herson VC, Daigle K. Diuretics for very low birth weight infants in the first 28 days: a survey of the U.S. neonatologists. J Perinatol 2011; 31(10): 677\u2013681. doi: https:\/\/doi.org\/10.1038\/jp.2011.11. PMID: 21394079.","DOI":"10.1038\/jp.2011.11"},{"key":"2705_CR29","doi-asserted-by":"publisher","unstructured":"Stewart A, Brion LP, Soll R. Diuretics for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2011; 2011(12): CD001454. doi: https:\/\/doi.org\/10.1002\/14651858.CD001454.pub3. PMID: 22161366; PMCID: PMC7055205.","DOI":"10.1002\/14651858.CD001454.pub3"},{"key":"2705_CR30","doi-asserted-by":"publisher","unstructured":"Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L. Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide. J Bone Miner Res 2006; 21(1): 163\u2013170. doi: https:\/\/doi.org\/10.1359\/JBMR.051003. PMID: 16355285.","DOI":"10.1359\/JBMR.051003"},{"key":"2705_CR31","doi-asserted-by":"publisher","unstructured":"Orth LE, O'Mara KL. Impact of early versus late diuretic exposure on metabolic bone disease and growth in premature neonates. J Pediatr Pharmacol Ther. 2018; 23(1): 26\u201333. doi: https:\/\/doi.org\/10.5863\/1551-6776-23.1.26. PMID: 29491749; PMCID: PMC5823489.","DOI":"10.5863\/1551-6776-23.1.26"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02705-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-021-02705-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02705-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T06:03:05Z","timestamp":1621231385000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-021-02705-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,17]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2705"],"URL":"https:\/\/doi.org\/10.1186\/s12887-021-02705-0","relation":{},"ISSN":["1471-2431"],"issn-type":[{"type":"electronic","value":"1471-2431"}],"subject":[],"published":{"date-parts":[[2021,5,17]]},"assertion":[{"value":"3 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Ethical Committee of the Zhangzhou Hospital. The study was based on register data, and individual informed consent from each participant is not required by waiver from the Ethical Committee and national guidelines. All the patient-related information was anonymized. The Hospital Institution authorized the administrative permission to the study team to access the data for research purpose on the nature of public health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}